Performance
Total traded value
0.21 CrFundamentals
| Market Cap | ₹1,873Cr |
| ROE | 21.52% |
| P/E Ratio(TTM) | 44.15 |
| EPS(TTM) | 42.02 |
| P/B Ratio | 9.50 |
| Dividend Yield | 0.00% |
| Industry P/E | 34.63 |
| Book Value | 195.25 |
| Debt to Equity | 0.67 |
| Face Value | 10 |
Financials
*All values are in Rs. Cr
About Beta Drugs
Beta Drugs Limited is a leading Indian pharmaceutical company dedicated to the oncology segment, specializing in manufacturing and trading cancer-related medicines for the branded market. Its strategy centers on achieving differentiation in the market through a focus on novel drug delivery and innovative formulation development to provide unique healthcare solutions. The company has established itself as a significant player, ranking among the top 10 oncology companies operating within India's competitive pharmaceutical landscape.;
| Parent Organisation | Beta Drugs Limited |
| Managing Director | Mr. Vijay Batra |
Shareholding Pattern
Sep '24
Nov '24
Dec '24
Mar '25
Jun '25